Table 1.
Patient’s characteristics.
| Variable | Number (%) |
|---|---|
| Age < 60 years | 92 (72.4%) |
| Age ≥ 60 years | 35 (27.6%) |
| ECOG performance status | |
| 0–1 | 116 (91.3%) |
| 2 or more | 11 (8.7%) |
| High LDH | 49 (38.6%) |
| Stage | |
| I | 49 (38.6%) |
| II | 78 (68.4%) |
| Stage adjusted IPI | |
| 0 | 23 (18.1%) |
| 1 | 51 (40.2%) |
| 2 | 37 (29.1%) |
| 3 | 15 (11.8%) |
| 4 | 1 (0.8%) |
| Extranodal localization | 51 (40.2%) |
| Nodal localization | |
| Head and neck | 33 (25.9%) |
| Mediastinal | 24 (18.9%) |
| Axillary | 4 (3.2%) |
| Abdominal/inguinal | 15 (11.8%) |
| Number of chemotherapy cycles | |
| < 6 | 23 (18.1%) |
| 6–8 | 104 (81.9%) |
| Radiotherapy | 82 (64.6%) |
| Treatment | |
| 3–4 cycles of chemotherapy with radiotherapy | 21 (16.6%) |
| 6 or cycles of chemotherapy with radiotherapy | 61 (48%) |
| Chemotherapy only | 45 (35.4%) |
| Maximum diameter on either CT plane | |
| ≤ 7.5 cm | 75 (59.1%) |
| >7.5 cm | 52 (40.9%) |
| Maximum diameter on transverse plane | |
| ≤ 7.5 cm | 84 (66.1%) |
| >7.5 cm | 43 (33.9%) |
| Maximum diameter on coronal plane | |
| ≤ 7.5 cm | 89 (70%) |
| >7.5 cm | 38 (30%) |
ECOG, Eastern Cooperative Oncology Group; LDH, lactate dehydrogenase; IPI, international prognostic index.